The UC Cancer Consortium Molecular Tumor Board (UCCC MTB) brings together precision oncology experts from across the UC system to discuss available biomarker-driven therapies for individual patients, ensuring systemwide awareness of the latest cutting-edge treatment options in cancer care.
UCCC MTB 2023-2024 meetings occur bi-monthly, and participation is limited to UC affiliates with valid UC email addresses. For more information, contact the UC Cancer Consortium at UCCancer@ucop.edu.
UCCC Molecular Tumor Board Virtual Meeting
March 12, 2024 at 8am PT (*New date!)
Register for the Zoom meeting here.
Future meeting dates
May 14, 2024
Submit a case
Referring physicians from UC academic health centers may submit active patient cases in advance of MTB meetings. To submit a case, please:
1. Download and complete a case summary form.
2. Upload the completed case summary form and relevant genomics report to the UCCC MTB Secure Box Folder.
Improving the lives of cancer patients with the most difficult cases
We engage providers and experts from across the UC system to make the best possible clinical care recommendations not only for each disease type, but for each individual patient.
The UCCC MTB is jointly led by representatives from all UC academic health centers. Contact the UC Cancer Consortium at UCCancer@ucop.edu for more information.